• 검색 결과가 없습니다.

■S-496■Serum phosphorus levels are associated with intradialytic hypotension in hemodialysis patients

N/A
N/A
Protected

Academic year: 2022

Share "■S-496■Serum phosphorus levels are associated with intradialytic hypotension in hemodialysis patients"

Copied!
1
0
0

로드 중.... (전체 텍스트 보기)

전체 글

(1)

539

2020년 제 71차 대한내과학회 추계학술대회

S-496 ■ Serum phosphorus levels are associated with intradialytic hypotension

in hemodialysis patients

성균관대학교 삼성창원병원 내과 임덕길, 이유지, 조성, 김성록

Background/Aims: Intradialytic hypotension (IDH) is a common serious complication in hemodialysis (HD) patients.

Hyperphosphatemia is also common in HD patients and promotes vascular calcification. Given the association between vascular calcification and IDH, we sought to investigate the association between IDH and serum phosphorus levels in HD patients.

Methods: We enrolled 173 adult patients who received maintenance HD for at least 3 months or more. IDH was defined as a nadir systolic blood pressure <90 mmHg or the occurrence of a hypotension-related symptom requiring intervention, including bolus fluid administration and cessation of fluid removal, at least once during three consecutive HD treatments. Serum phosphorus levels were analyzed both as a continuous variable and as a categorical variable [< 4.0, 4.0–5.5 (reference), and ≥ 5.5 mg/dL].

Results: IDH occurred in 47 (30%) of the 173 HD patients. Mean [SD] phosphorus level was 4.9 [1.6] mg/dL. Each increase in serum phosphorus of 1 mg/dL was associated with 2.5-fold increased odds for developing IDH. The fully adjusted odds ratio (OR) and 95%

confidence intervals (CIs) were 2.51 (1.76–3.60). Serum phosphorus was significantly associated with IDH even after adjusting for ultrafiltration rate; the OR and 95% CIs were 2.50 (1.74–3.58). High categorized phosphorus levels were also associated with IDH.

Serum phosphorus ≥5.5 mg/dL was associated with 7.6-fold increased odds of developing IDH compared to serum phosphorus levels between 4.0 to <5.5 mg/dL (reference level); the fully adjusted OR and 95% CIs were 7.61 (2.76–21.03). On the other hand, serum phosphorus <4.0 was associated with decreased odds of IDH. In subgroup analyses, diabetes modified the association between IDH and phosphorus levels, with a more pronounced association in diabetic patients.

Conclusions: In HD patients, higher phosphorus levels were significantly associated with an increased occurrence of IDH. Therefore, strictly controlling phosphorus levels may be effective in reducing IDH in HD patients.

참조

관련 문서

Objectives: This study was performed to investigate whether serum calprotectin levels are increased in patients with adult-onset Still’s disease (AOSD) and whether its

Although phosphate levels are known to be associated with adverse outcome in patients with acute kidney injury, it is not well known whether serum high phosphate levels are

We compared clinical charac- teristics and the plasma levels of endocan between 53 patients with cardiovascular composite outcomes and 347 control patients without

Background: In the current study, we investigated whether the laboratory and clinical manifestations of SS patients were associated with CCL21 and CXCL13 expression levels

In present study, we aimed to evaluate the correlation between serum level of MC mediators (histamine, tryptase, and chymase) and disease activity/autoantibody levels of

Conclusion: Serum and SF levels of TL1A were significantly increased in RA patients compared with OA patients, and correlated well with clinical parameters

This study was performed to evaluate the association between blood levels of heavy metals and lung function in a cohort of chronic obstructive pulmonary disease (COPD)

We aimed to investigate the prognostic effect of various biomarkers – p53, EGRF, HER-2, E-cadherin, Ki-67- in patients with gastric cancer.. Methods: Between January 2014